Lisata Therapeutics Ownership 2024 | Who Owns Lisata Therapeutics Now?

OverviewFinancials Chart Transcripts

Institutional Ownership

12.35%

Insider Ownership

18.75%

Retail Ownership

68.90%

Institutional Holders

18.00

Lisata Therapeutics Institutional Shareholders

Institutional Shareholders by % of Total Shares

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
BML CAPITAL MANAGEMENT, LLC	4.71%	0.68%	243,839	-	-	791,258,000	Mar 31, 2023
VANGUARD GROUP INC	3.40%	-	176,139	-	-	571,571,000	Mar 31, 2023
RENAISSANCE TECHNOLOGIES LLC	1.78%	0.00%	92,422	300	0.33%	300,000	Mar 31, 2023
BLACKROCK INC.	1.10%	-	56,806	-	-	184,335,000	Mar 31, 2023
GEODE CAPITAL MANAGEMENT, LLC	0.50%	-	25,973	-	-	84,412,000	Mar 31, 2023
DIMENSIONAL FUND ADVISORS LP	0.29%	-	14,951	-	-	48,591,000	Mar 31, 2023
STATE STREET CORP	0.28%	-	14,348	-	-	46,631,000	Mar 31, 2023
COOK WEALTH MANAGEMENT GROUP LLC	0.23%	0.03%	12,175	-	-	39,569,000	Mar 31, 2023
MORGAN STANLEY	0.03%	-	1,549	-	-	5,026,000	Mar 31, 2023
TOWER RESEARCH CAPITAL LLC (TRC)	0.01%	0.00%	691	-905	-56.70%	2,000	Mar 31, 2023
FOUNDERS CAPITAL MANAGEMENT	0.01%	0.00%	666	-	-	2,000	Mar 31, 2023
WELLS FARGO & COMPANY/MN	0.00%	-	29	-	-	94,000	Mar 31, 2023
BANK OF AMERICA CORP /DE/	0.00%	-	26	-20	-43.48%	84,000	Mar 31, 2023
NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO	0.00%	-	20	-	-	65,000	Mar 31, 2023
PACIFIC CENTER FOR FINANCIAL SERVICES	0.00%	-	8	8	100.00%	26,000	Mar 31, 2023
ADVISOR GROUP HOLDINGS, INC.	0.00%	-	3	3	100.00%	9,000	Mar 31, 2023
UBS GROUP AG	-	-	1	-5,896	-99.98%	3,000	Mar 31, 2023
FMR LLC	-	-	1	-	-	3,000	Mar 31, 2023
GROUP ONE TRADING, L.P.	-	-	-	-79,000	-100.00%	-	Mar 31, 2023
CITADEL ADVISORS LLC	-	-	-	-2,250	-100.00%	-	Mar 31, 2023

Lisata Therapeutics's largest institutional shareholder is BML CAPITAL MANAGEMENT, LLC, holding 4.71% of the company's total share outstanding, currently valued at $791.26M. The top 10 institutional shareholders own together 12.33% of the company.

Institutional Shareholders by % of Total Assets

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
BML CAPITAL MANAGEMENT, LLC	4.71%	0.68%	243,839	-	-	791,258,000	Mar 31, 2023
COOK WEALTH MANAGEMENT GROUP LLC	0.23%	0.03%	12,175	-	-	39,569,000	Mar 31, 2023
FOUNDERS CAPITAL MANAGEMENT	0.01%	0.00%	666	-	-	2,000	Mar 31, 2023
RENAISSANCE TECHNOLOGIES LLC	1.78%	0.00%	92,422	300	0.33%	300,000	Mar 31, 2023
TOWER RESEARCH CAPITAL LLC (TRC)	0.01%	0.00%	691	-905	-56.70%	2,000	Mar 31, 2023
DIMENSIONAL FUND ADVISORS LP	0.29%	-	14,951	-	-	48,591,000	Mar 31, 2023
VANGUARD GROUP INC	3.40%	-	176,139	-	-	571,571,000	Mar 31, 2023
GEODE CAPITAL MANAGEMENT, LLC	0.50%	-	25,973	-	-	84,412,000	Mar 31, 2023
PACIFIC CENTER FOR FINANCIAL SERVICES	0.00%	-	8	8	100.00%	26,000	Mar 31, 2023
BLACKROCK INC.	1.10%	-	56,806	-	-	184,335,000	Mar 31, 2023
STATE STREET CORP	0.28%	-	14,348	-	-	46,631,000	Mar 31, 2023
MORGAN STANLEY	0.03%	-	1,549	-	-	5,026,000	Mar 31, 2023
NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO	0.00%	-	20	-	-	65,000	Mar 31, 2023
WELLS FARGO & COMPANY/MN	0.00%	-	29	-	-	94,000	Mar 31, 2023
ADVISOR GROUP HOLDINGS, INC.	0.00%	-	3	3	100.00%	9,000	Mar 31, 2023
BANK OF AMERICA CORP /DE/	0.00%	-	26	-20	-43.48%	84,000	Mar 31, 2023
UBS GROUP AG	-	-	1	-5,896	-99.98%	3,000	Mar 31, 2023
FMR LLC	-	-	1	-	-	3,000	Mar 31, 2023
GROUP ONE TRADING, L.P.	-	-	-	-146	-100.00%	-	Mar 31, 2023
CITADEL ADVISORS LLC	-	-	-	-10,082	-100.00%	-	Mar 31, 2023

The largest Lisata Therapeutics shareholder by % of total assets is BML CAPITAL MANAGEMENT, LLC. The company owns 243.84K shares of Lisata Therapeutics (LSTA), representing 0.68% of its total assets.

Institutional Buyers

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
RENAISSANCE TECHNOLOGIES LLC	1.78%	0.00%	92,422	300	0.33%	300,000	Mar 31, 2023
PACIFIC CENTER FOR FINANCIAL SERVICES	0.00%	-	8	8	100.00%	26,000	Mar 31, 2023
ADVISOR GROUP HOLDINGS, INC.	0.00%	-	3	3	100.00%	9,000	Mar 31, 2023
FMR LLC	-	-	1	-	-	3,000	Mar 31, 2023
WELLS FARGO & COMPANY/MN	0.00%	-	29	-	-	94,000	Mar 31, 2023
NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO	0.00%	-	20	-	-	65,000	Mar 31, 2023
MORGAN STANLEY	0.03%	-	1,549	-	-	5,026,000	Mar 31, 2023
STATE STREET CORP	0.28%	-	14,348	-	-	46,631,000	Mar 31, 2023
BLACKROCK INC.	1.10%	-	56,806	-	-	184,335,000	Mar 31, 2023
GEODE CAPITAL MANAGEMENT, LLC	0.50%	-	25,973	-	-	84,412,000	Mar 31, 2023
VANGUARD GROUP INC	3.40%	-	176,139	-	-	571,571,000	Mar 31, 2023
DIMENSIONAL FUND ADVISORS LP	0.29%	-	14,951	-	-	48,591,000	Mar 31, 2023
FOUNDERS CAPITAL MANAGEMENT	0.01%	0.00%	666	-	-	2,000	Mar 31, 2023
COOK WEALTH MANAGEMENT GROUP LLC	0.23%	0.03%	12,175	-	-	39,569,000	Mar 31, 2023
BML CAPITAL MANAGEMENT, LLC	4.71%	0.68%	243,839	-	-	791,258,000	Mar 31, 2023
IFP ADVISORS, INC	-	-	-	-7	-100.00%	-	Mar 31, 2023
BANK OF AMERICA CORP /DE/	0.00%	-	26	-20	-43.48%	84,000	Mar 31, 2023
GROUP ONE TRADING, L.P.	-	-	-	-146	-100.00%	-	Mar 31, 2023
TOWER RESEARCH CAPITAL LLC (TRC)	0.01%	0.00%	691	-905	-56.70%	2,000	Mar 31, 2023
CITADEL ADVISORS LLC	-	-	-	-2,250	-100.00%	-	Mar 31, 2023

As of Mar 31 2023, Lisata Therapeutics's largest institutional buyer is RENAISSANCE TECHNOLOGIES LLC. The company purchased 300.00 stocks of LSTA, valued at $300.00K.

Institutional Sellers

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
GROUP ONE TRADING, L.P.	-	-	-	-79,000	-100.00%	-	Mar 31, 2023
SABBY MANAGEMENT, LLC	-	-	-	-68,462	-100.00%	-	Mar 31, 2023
CITADEL ADVISORS LLC	-	-	-	-10,082	-100.00%	-	Mar 31, 2023
UBS GROUP AG	-	-	1	-5,896	-99.98%	3,000	Mar 31, 2023
CITADEL ADVISORS LLC	-	-	-	-2,250	-100.00%	-	Mar 31, 2023
TOWER RESEARCH CAPITAL LLC (TRC)	0.01%	0.00%	691	-905	-56.70%	2,000	Mar 31, 2023
GROUP ONE TRADING, L.P.	-	-	-	-146	-100.00%	-	Mar 31, 2023
BANK OF AMERICA CORP /DE/	0.00%	-	26	-20	-43.48%	84,000	Mar 31, 2023
IFP ADVISORS, INC	-	-	-	-7	-100.00%	-	Mar 31, 2023
BML CAPITAL MANAGEMENT, LLC	4.71%	0.68%	243,839	-	-	791,258,000	Mar 31, 2023
COOK WEALTH MANAGEMENT GROUP LLC	0.23%	0.03%	12,175	-	-	39,569,000	Mar 31, 2023
FOUNDERS CAPITAL MANAGEMENT	0.01%	0.00%	666	-	-	2,000	Mar 31, 2023
DIMENSIONAL FUND ADVISORS LP	0.29%	-	14,951	-	-	48,591,000	Mar 31, 2023
VANGUARD GROUP INC	3.40%	-	176,139	-	-	571,571,000	Mar 31, 2023
GEODE CAPITAL MANAGEMENT, LLC	0.50%	-	25,973	-	-	84,412,000	Mar 31, 2023
BLACKROCK INC.	1.10%	-	56,806	-	-	184,335,000	Mar 31, 2023
STATE STREET CORP	0.28%	-	14,348	-	-	46,631,000	Mar 31, 2023
MORGAN STANLEY	0.03%	-	1,549	-	-	5,026,000	Mar 31, 2023
NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO	0.00%	-	20	-	-	65,000	Mar 31, 2023
WELLS FARGO & COMPANY/MN	0.00%	-	29	-	-	94,000	Mar 31, 2023

As of Mar 31 2023, Lisata Therapeutics's biggest institutional seller is GROUP ONE TRADING, L.P.. The company sold -79.00K shares of LSTA, valued at -.

Institutional New positions

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
PACIFIC CENTER FOR FINANCIAL SERVICES	0.00%	-	8	8	100.00%	26,000	Mar 31, 2023
ADVISOR GROUP HOLDINGS, INC.	0.00%	-	3	3	100.00%	9,000	Mar 31, 2023

Lisata Therapeutics's largest new institutional shareholder by number of shares is PACIFIC CENTER FOR FINANCIAL SERVICES, purchased 8.00 shares, valued at $26.00K, as of undefined.

Institutional Sold Out

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
GROUP ONE TRADING, L.P.	-	-	-	-79,000	-100.00%	-	Mar 31, 2023
SABBY MANAGEMENT, LLC	-	-	-	-68,462	-100.00%	-	Mar 31, 2023
CITADEL ADVISORS LLC	-	-	-	-10,082	-100.00%	-	Mar 31, 2023
CITADEL ADVISORS LLC	-	-	-	-2,250	-100.00%	-	Mar 31, 2023
GROUP ONE TRADING, L.P.	-	-	-	-146	-100.00%	-	Mar 31, 2023
IFP ADVISORS, INC	-	-	-	-7	-100.00%	-	Mar 31, 2023

Lisata Therapeutics's largest sold out institutional shareholder by shares sold is GROUP ONE TRADING, L.P., sold -79.00K shares, valued at -, as of undefined.

Lisata Therapeutics Mutual Fund Holders

Name	% Total Assets	Total Shares	Change Amount	Change %	Date
VANGUARD INDEX FUNDS	0.00%	180,659	-52,869	-22.64%	Mar 31, 2024
FIDELITY CONCORD STREET TRUST	0.00%	42,101	721	1.74%	Feb 29, 2024
VANGUARD INSTITUTIONAL INDEX FUNDS	0.00%	231	-	-	Mar 31, 2024
Dimensional ETF Trust	0.00%	2,622	-	-	Jan 31, 2024
DFA INVESTMENT DIMENSIONS GROUP INC	0.00%	3,850	-	-	Jan 31, 2024
USAA MUTUAL FUNDS TRUST	0.00%	874	-	-	Jan 31, 2024

Lisata Therapeutics's largest mutual fund holder by % of total assets is "VANGUARD INDEX FUNDS", owning 180.66K shares, compromising 0.00% of its total assets.

Lisata Therapeutics Institutional Ownership Trends

Institutional Holdings Trend

Date	Holdings	Change %
31 Mar, 23	18	-10.00%
31 Dec, 22	20	53.85%
30 Sep, 22	13	-

As of 31 Mar 23, 18 institutions are holding Lisata Therapeutics's shares, representing a decrease of -10.00% compared to the previous quarter.

Shares Outstanding Trend

Date	Shares Outstanding	Change %
31 Mar, 23	639,647	-11.76%
31 Dec, 22	724,854	54.09%
30 Sep, 22	470,408	-

Lisata Therapeutics (LSTA) has 639.65K shares outstanding as of 31 Mar 23, down -11.76% compared to the previous quarter.

Institutional Ownership Trend

Date	Ownership %	Change %
31 Mar, 23	12.35%	-19.13%
31 Dec, 22	15.27%	31.00%
30 Sep, 22	11.66%	-

As of 31 Mar 23, Lisata Therapeutics is held by 12.35% institutional shareholders, representing a -19.13% negative growth compared to 31 Dec 22.

Institutional Increased Positions Trend

Date	Increased Positions	Change %
31 Mar, 23	1	-75.00%
31 Dec, 22	4	-
30 Sep, 22	-	-

1 institutional shareholders have increased their position in LSTA stock as of 31 Mar 23 compared to 4 in the previous quarter (a -75.00% decrease).

Institutional Reduced Positions Trend

Date	Reduced Positions	Change %
31 Mar, 23	3	-50.00%
31 Dec, 22	6	-
30 Sep, 22	-	-

3 institutional shareholders have reduced their position in LSTA stock as of 31 Mar 23 compared to 6 in the previous quarter (a -50.00% decrease).

All Institutional Ownership Trend Data

Date	Holdings	Change %	Shares Outstanding	Change %	Ownership %	Change %	Increased Positions	Change %	Reduced Positions	Change %
31 Mar, 23	18	-10.00%	639,647	-11.76%	12.35%	-19.13%	1	-75.00%	3	-50.00%
31 Dec, 22	20	53.85%	724,854	54.09%	15.27%	31.00%	4	-	6	-
30 Sep, 22	13	-	470,408	-	11.66%	-	-	-	-	-

Lisata Therapeutics Insider Shareholders Trades

Open Market Insider Trades

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held	Source

Open Market Insider Buys

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held	Source

Insider Sells

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held
Apr 24, 2024	Nisco James	officer	See Remarks		Sell	-	-	-	11,357
Apr 24, 2024	Nisco James	officer	See Remarks		Sell	64	$580.50	$37.15K	-
Apr 24, 2024	Nisco James	officer	See Remarks		Sell	66	$339.00	$22.37K	-
Apr 24, 2024	Nisco James	officer	See Remarks		Sell	33	$94.50	$3.12K	-
Apr 24, 2024	Nisco James	officer	See Remarks		Sell	398	$71.55	$28.48K	-
Apr 24, 2024	Nisco James	officer	See Remarks		Sell	39	$53.10	$2.07K	-
Apr 24, 2024	Nisco James	officer	See Remarks		Sell	140	$56.85	$7.96K	-
Apr 24, 2024	Nisco James	officer	See Remarks		Sell	168	$74.25	$12.47K	-
Apr 24, 2024	Nisco James	officer	See Remarks		Sell	201	$49.20	$9.89K	-
Apr 24, 2024	Nisco James	officer	See Remarks		Sell	466	$23.85	$11.11K	-
Apr 24, 2024	Nisco James	officer	See Remarks		Sell	1,466	$13.76	$20.17K	-
Apr 24, 2024	Nisco James	officer	See Remarks		Sell	3,000	$3.00	$9.00K	-
Apr 24, 2024	Nisco James	officer	See Remarks		Sell	4,000	$3.08	$12.32K	-
Jan 12, 2024	Mazzo David J	director, officer	Chief Executive Officer	F-InKind	Sell	1,026	$2.99	$3.07K	174,766
Jan 11, 2024	Buck Kristen K	officer	EVP, R&D and CMO	F-InKind	Sell	3,221	$3.08	$9.92K	56,694
Jan 11, 2024	Buck Kristen K	officer	EVP, R&D and CMO	F-InKind	Sell	2,147	$3.08	$6.61K	54,547
Jan 11, 2024	Buck Kristen K	officer	EVP, R&D and CMO	F-InKind	Sell	512	$3.00	$1.54K	54,035

All Insider Owners Trades

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held
Apr 24, 2024	Nisco James	officer	See Remarks		Sell	-	-	-	11,357
Apr 24, 2024	Nisco James	officer	See Remarks		Sell	64	$580.50	$37.15K	-
Apr 24, 2024	Nisco James	officer	See Remarks		Sell	66	$339.00	$22.37K	-
Apr 24, 2024	Nisco James	officer	See Remarks		Sell	33	$94.50	$3.12K	-
Apr 24, 2024	Nisco James	officer	See Remarks		Sell	398	$71.55	$28.48K	-
Apr 24, 2024	Nisco James	officer	See Remarks		Sell	39	$53.10	$2.07K	-
Apr 24, 2024	Nisco James	officer	See Remarks		Sell	140	$56.85	$7.96K	-
Apr 24, 2024	Nisco James	officer	See Remarks		Sell	168	$74.25	$12.47K	-
Apr 24, 2024	Nisco James	officer	See Remarks		Sell	201	$49.20	$9.89K	-
Apr 24, 2024	Nisco James	officer	See Remarks		Sell	466	$23.85	$11.11K	-
Apr 24, 2024	Nisco James	officer	See Remarks		Sell	1,466	$13.76	$20.17K	-
Apr 24, 2024	Nisco James	officer	See Remarks		Sell	3,000	$3.00	$9.00K	-
Apr 24, 2024	Nisco James	officer	See Remarks		Sell	4,000	$3.08	$12.32K	-
Jan 12, 2024	Mazzo David J	director, officer	Chief Executive Officer	F-InKind	Sell	1,026	$2.99	$3.07K	174,766
Jan 11, 2024	Buck Kristen K	officer	EVP, R&D and CMO	A-Award	Buy	27,000	-	-	59,915
Jan 11, 2024	Buck Kristen K	officer	EVP, R&D and CMO	F-InKind	Sell	3,221	$3.08	$9.92K	56,694
Jan 11, 2024	Buck Kristen K	officer	EVP, R&D and CMO	F-InKind	Sell	2,147	$3.08	$6.61K	54,547
Jan 11, 2024	Buck Kristen K	officer	EVP, R&D and CMO	F-InKind	Sell	512	$3.00	$1.54K	54,035
Jan 11, 2024	Buck Kristen K	officer	EVP, R&D and CMO	A-Award	Buy	14,000	$3.08	$43.12K	14,000
Jan 11, 2024	Mazzo David J	director, officer	Chief Executive Officer	A-Award	Buy	94,000	-	-	199,308

The last insider sell of Lisata Therapeutics's stock was made by Nisco James on Apr 24 2024, selling - shares at - per share (valued at -).

Lisata Therapeutics Insider Ownership Trends

All Insider Trades Trend

Date	Buy	Sell	Buy/Sell Ratio
Q1 2024	9	7	128.57%
Q3 2023	-	1	-
Q1 2023	12	7	171.43%
Q3 2022	1	-	-
Q2 2022	-	1	-
Q1 2022	13	9	144.44%
Q4 2021	1	1	100.00%
Q3 2021	2	1	200.00%
Q1 2021	1	6	16.67%
Q4 2019	-	1	-
Q3 2019	-	1	-

9 total buy trades, and 7 total sell trades (buy/sell ratio of 1.29%) were made by Lisata Therapeutics's insiders, as of Q1 2024.

Open Market Insider Trades Trend

Date	Buy	Sell	Buy/Sell Ratio
Q1 2024	-	-	-
Q3 2023	-	-	-
Q1 2023	-	-	-
Q3 2022	-	-	-
Q2 2022	-	-	-
Q1 2022	-	-	-
Q4 2021	1	-	-
Q3 2021	-	-	-
Q1 2021	-	-	-
Q4 2019	-	-	-
Q3 2019	-	-	-

As of Q1 2024, Insider owners conducted 0 open market buy trades and 0 open market sell trades of Lisata Therapeutics's stocks.

Lisata Therapeutics Peer Ownership

Ticker	Company
CYT	Cyteir Therapeutics, Inc.
PULM	Pulmatrix, Inc.
HSTO	Histogen Inc.
BPTH	Bio-Path Holdings, Inc.
IMNN	Imunon, Inc.
LIXT	Lixte Biotechnology Holdings, Inc.
ALPN	Alpine Immune Sciences, Inc.
ANTX	AN2 Therapeutics, Inc.
KA	Kineta, Inc.
GLUE	Monte Rosa Therapeutics, Inc.
RZLT	Rezolute, Inc.
CADL	Candel Therapeutics, Inc.
TPST	Tempest Therapeutics, Inc.
MBRX	Moleculin Biotech, Inc.
ONTX	Traws Pharma, Inc.
PTIX	Protagenic Therapeutics, Inc.
CBIO	Gyre Therapeutics, Inc.

LSTA Ownership FAQ

Who Owns Lisata Therapeutics?

Lisata Therapeutics is owned by institutional shareholders (12.35%), insiders (18.75%), and public (68.90%). The largest institutional shareholder of Lisata Therapeutics is BML CAPITAL MANAGEMENT, LLC (4.71% of total shares) and the top mutual fund owner is VANGUARD INDEX FUNDS (0.00% of total shares).

Who are the major institutional shareholders of Lisata Therapeutics?

Lisata Therapeutics's major institutional shareholders are BML CAPITAL MANAGEMENT, LLC, VANGUARD GROUP INC, RENAISSANCE TECHNOLOGIES LLC, BLACKROCK INC., and GEODE CAPITAL MANAGEMENT, LLC. The top five shareholders own together 11.49% of the company's share outstanding.

How many Lisata Therapeutics shareholders are there?

As of Mar 2023, there are 18 institutional shareholders of Lisata Therapeutics.

What percentage of Lisata Therapeutics is owned by BML CAPITAL MANAGEMENT, LLC?

BML CAPITAL MANAGEMENT, LLC owns 243.84K shares of Lisata Therapeutics, representing 4.71% of the company's total shares outstanding, valued at $791.26M (as of Mar 2023).

What percentage of Lisata Therapeutics is owned by VANGUARD GROUP INC?

As of Mar 2023, VANGUARD GROUP INC holds 176.14K shares of Lisata Therapeutics (LSTA), compromising 3.40% of the company, valued at $571.57M.

What percentage of Lisata Therapeutics is owned by RENAISSANCE TECHNOLOGIES LLC?

RENAISSANCE TECHNOLOGIES LLC is the third largest holder of Lisata Therapeutics. The company owns 92.42K of the company's shares outstanding (worth $300K).